171 related articles for article (PubMed ID: 17159769)
1. Oxidative detoxication of carcinogenic 2-nitroanisole by human, rat and rabbit cytochrome P450.
Dracínska H; Miksanová M; Svobodová M; Smrcek S; Frei E; Schmeiser HH; Stiborová M
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():9-13. PubMed ID: 17159769
[TBL] [Abstract][Full Text] [Related]
2. Enzymes involved in the metabolism of the carcinogen 2-nitroanisole: evidence for its oxidative detoxication by human cytochromes P450.
Miksanová M; Sulc M; Rýdlová H; Schmeiser HH; Frei E; Stiborová M
Chem Res Toxicol; 2004 May; 17(5):663-71. PubMed ID: 15144223
[TBL] [Abstract][Full Text] [Related]
3. Redox cycling in the metabolism of the environmental pollutant and suspected human carcinogen o-anisidine by rat and rabbit hepatic microsomes.
Naiman K; Dracínská H; Martínková M; Sulc M; Dracínský M; Kejíková L; Hodek P; Hudecek J; Liberda J; Schmeiser HH; Frei E; Stiborová M
Chem Res Toxicol; 2008 Aug; 21(8):1610-21. PubMed ID: 18624415
[TBL] [Abstract][Full Text] [Related]
4. Rat cytochromes P450 oxidize 2-nitrophenol, a human metabolite of carcinogenic 2-nitroanisole.
Svobodova M; Martinkova M; Dracinska H; Frei E; Stiborova M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():46-51. PubMed ID: 20027144
[TBL] [Abstract][Full Text] [Related]
5. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene.
Shou M; Korzekwa KR; Krausz KW; Buters JT; Grogan J; Goldfarb I; Hardwick JP; Gonzalez FJ; Gelboin HV
Mol Carcinog; 1996 Dec; 17(4):241-9. PubMed ID: 8989918
[TBL] [Abstract][Full Text] [Related]
6. Identification of a genotoxic mechanism for 2-nitroanisole carcinogenicity and of its carcinogenic potential for humans.
Stiborová M; Miksanová M; Smrcek S; Bieler CA; Breuer A; Klokow KA; Schmeiser HH; Frei E
Carcinogenesis; 2004 May; 25(5):833-40. PubMed ID: 14729594
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of carcinogenic 2-nitroanisole by rat cytochromes P450 - similarity between human and rat enzymes.
Svobodová M; Dračínská H; Martínková M; Hudeček J; Hodek P; Frei E; Stiborová M
Interdiscip Toxicol; 2008 Sep; 1(2):182-5. PubMed ID: 21218109
[TBL] [Abstract][Full Text] [Related]
8. Human cytochrome-P450 enzymes metabolize N-(2-methoxyphenyl)hydroxylamine, a metabolite of the carcinogens o-anisidine and o-nitroanisole, thereby dictating its genotoxicity.
Naiman K; Martínková M; Schmeiser HH; Frei E; Stiborová M
Mutat Res; 2011 Dec; 726(2):160-8. PubMed ID: 21946300
[TBL] [Abstract][Full Text] [Related]
9. Carcinogenic pollutants o-nitroanisole and o-anisidine are substrates and inducers of cytochromes P450.
Rýdlová H; Miksanová M; Ryslavá H; Stiborová M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):441-7. PubMed ID: 16601807
[TBL] [Abstract][Full Text] [Related]
10. Identification of rat cytochromes P450 metabolizing N-(2-methoxyphenyl)hydroxylamine, a human metabolite of the environmental pollutants and carcinogens o-anisidine and o-nitroanisole.
Naiman K; Frei E; Stiborova M
Neuro Endocrinol Lett; 2010; 31 Suppl 2():36-45. PubMed ID: 21187827
[TBL] [Abstract][Full Text] [Related]
11. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1.
Goosen TC; Mills DE; Hollenberg PF
J Pharmacol Exp Ther; 2001 Jan; 296(1):198-206. PubMed ID: 11123381
[TBL] [Abstract][Full Text] [Related]
12. Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes.
Stiborová M; Martínek V; Rýdlová H; Hodek P; Frei E
Cancer Res; 2002 Oct; 62(20):5678-84. PubMed ID: 12384524
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
[TBL] [Abstract][Full Text] [Related]
14. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases.
Hammons GJ; Guengerich FP; Weis CC; Beland FA; Kadlubar FF
Cancer Res; 1985 Aug; 45(8):3578-85. PubMed ID: 4016738
[TBL] [Abstract][Full Text] [Related]
15. Induced expression of cytochrome P450 1A and NAD(P)H:quinone oxidoreductase determined at mRNA, protein, and enzyme activity levels in rats exposed to the carcinogenic azo dye 1-phenylazo-2-naphthol (Sudan I).
Stiborová M; Dračínská H; Martínek V; Svášková D; Hodek P; Milichovský J; Hejduková Ž; Brotánek J; Schmeiser HH; Frei E
Chem Res Toxicol; 2013 Feb; 26(2):290-9. PubMed ID: 23289503
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450.
Shou M; Krausz KW; Gonzalez FJ; Gelboin HV
Arch Biochem Biophys; 1996 Apr; 328(1):201-7. PubMed ID: 8638931
[TBL] [Abstract][Full Text] [Related]
18. In vitro hepatic metabolism of cediranib, a potent vascular endothelial growth factor tyrosine kinase inhibitor: interspecies comparison and human enzymology.
Schulz-Utermoehl T; Spear M; Pollard CR; Pattison C; Rollison H; Sarda S; Ward M; Bushby N; Jordan A; Harrison M
Drug Metab Dispos; 2010 Oct; 38(10):1688-97. PubMed ID: 20634336
[TBL] [Abstract][Full Text] [Related]
19. Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s.
Asai H; Imaoka S; Kuroki T; Monna T; Funae Y
J Pharmacol Exp Ther; 1996 May; 277(2):1004-9. PubMed ID: 8627510
[TBL] [Abstract][Full Text] [Related]
20. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.
Zerilli A; Ratanasavanh D; Lucas D; Goasduff T; Dréano Y; Menard C; Picart D; Berthou F
Chem Res Toxicol; 1997 Oct; 10(10):1205-12. PubMed ID: 9348445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
